82% of U.S. Doctors Now Answer to a Corporate Owner

Corporate entities including private equity firms, hospitals and insurance companies now employ 82% of practicing U.S. physicians, and those doctors say the ownership arrangement erodes their clinical autonomy, according to reporting published September 8, 2026 by Forbes.

Four out of every five practicing physicians in the United States now draw a paycheck from a corporate entity rather than from a practice they own. The figure is 82%, and the employers behind it span private equity firms, hospital systems and insurance companies — three sets of owners with very different balance sheets but a shared interest in the economics of a doctor's day.

The doctors themselves report that the arrangement erodes their autonomy. That is the part of the statistic that matters most, because autonomy is not a soft benefit in medicine. It determines how long an appointment runs, which referrals get made, which drugs get prescribed first, and whether a physician can decline to see one more patient at the end of a shift.

What Counts as a Corporate Employer Now

The category is broader than it once was. A hospital system that buys a cardiology group is a corporate employer. So is a health insurer that acquires primary care clinics and folds them into a delivery arm. So is a private equity sponsor that rolls up dermatology, anesthesiology or emergency medicine practices into a single platform, refinances the debt and sells the platform to another sponsor a few years later.

Each model produces a different pressure. Hospital ownership tends to pull physician referrals inside the system, keeping imaging, surgery and follow-up under one roof. Insurer ownership aligns the doctor with a payer's cost curve rather than a fee-for-service billing sheet. Private equity ownership carries an explicit exit clock: the sponsor has to deliver a return within a defined holding period, which puts steady upward pressure on volumes and downward pressure on anything that reads as overhead.

What all three share is that the clinical decision-maker is no longer the owner. The residual 18% of physicians who remain outside corporate employment — the arithmetic complement of the 82% figure, offered here as illustration rather than as a separately reported number — represent what is left of the independent practice model that defined American medicine for most of the twentieth century.

How Four in Five Became the Norm

Consolidation of this scale did not arrive in one transaction. It accumulated through a decade of small deals: a two-physician practice sold to a regional group, the regional group sold to a platform, the platform sold to a larger platform. Independent practices faced rising administrative costs, electronic records requirements, payer contracting leverage they could not match, and partners approaching retirement with no obvious buyer other than a corporate acquirer. Selling was frequently the rational choice for the individual seller, even as the aggregate result reshaped the profession.

The reporting on the 82% share comes from Forbes, which frames the shift in terms of the autonomy physicians say they have surrendered along the way.

Where the Financial Pressure Actually Lands

For investors, physician employment is the input cost that determines whether the whole model works. Doctors are the most expensive labor in a clinical business and the hardest to replace. A rollup that assumes flat compensation and rising throughput is making a bet on physician tolerance. When that tolerance runs out, it shows up first as turnover, then as locum tenens spending to fill gaps, then as deteriorating margins in the exact facilities the acquisition thesis was built around.

Burnout, unionization drives among employed physicians, and non-compete litigation are the visible symptoms of the same underlying tension. None of them appear on a deal model at signing. All of them can appear in the operating numbers two or three years later. The autonomy complaint is therefore not only a professional grievance; it is a leading indicator of labor cost in an industry where labor is the dominant expense line.

The Backdrop for Healthcare Capital

The consolidation has run alongside a long stretch of accommodative financing, which is what made leveraged rollups viable in the first place. Broad equity markets were softer in Tuesday trading: the S&P 500 tracker (NYSEARCA: SPY) changed hands at $766.84, down 0.43% from the prior close of $770.19, as of the last trade at 14:02 GMT on September 8, 2026. The Nasdaq 100 fund (NASDAQ: QQQ) was at $716.43, off 0.35%, and the Dow tracker (NYSEARCA: DIA) at $528.78, down 0.99% — the weakest of the three on the day.

Those are broad-market readings, not a verdict on healthcare services. But they matter to this story indirectly. A rollup strategy that depends on cheap debt and a receptive exit market behaves differently when financing costs and equity valuations tighten. When sponsors cannot sell platforms on schedule, they hold them longer and press harder on operations — which is precisely the pressure physicians describe.

What Would Change the Trajectory

Three things are worth watching. The first is regulation: state-level scrutiny of private equity in healthcare and of the corporate practice of medicine doctrine, which nominally restricts non-physician ownership in many states and has been navigated through management service organization structures. Any tightening there directly affects deal supply.

The second is physician bargaining power. Employed doctors organizing collectively is a different labor dynamic than independent practitioners negotiating individually, and it changes the cost assumptions underneath every acquisition made in the last decade.

The third is patient-facing evidence. If autonomy erosion translates into measurable changes in referral patterns, appointment length or care quality, the political case for intervention strengthens quickly. So far the loudest testimony is coming from the doctors themselves, and at 82% of the profession, that is not a fringe constituency. It is the profession.

For patients, the practical takeaway is smaller but immediate: the person across the desk increasingly works for an organization with its own financial objectives, and asking who owns the practice is now a reasonable question to bring to an appointment.

Key facts

• Physicians employed by corporate entities: 82% of U.S. practicing physicians
• Owner types included: Private equity firms, hospitals, insurance companies
• S&P 500 (SPY): $766.84, -0.43%, as of 14:02 GMT Sept. 8, 2026
• Dow 30 (DIA): $528.78, -0.99%, as of 14:02 GMT Sept. 8, 2026

Frequently asked questions

What share of U.S. doctors work for corporate entities?

Corporate entities employ 82% of practicing U.S. physicians — roughly four in five. That category covers private equity firms, hospital systems and insurance companies. The figure marks a substantial shift away from the independent, physician-owned practice model that dominated American medicine through most of the twentieth century.

What does 'erodes autonomy' mean in practice for a doctor?

Physicians report that corporate ownership reduces their control over clinical decisions. In practical terms that can mean less say over appointment length, patient volume targets, referral destinations within a system, and staffing. The owner rather than the practicing doctor sets the operating parameters, even where the clinical judgment remains the physician's.

Why did so many physician practices sell to corporate buyers?

Independent practices faced rising administrative and technology costs, weaker contracting leverage against large payers, and retiring partners with few buyers other than corporate acquirers. Selling was often the rational individual decision. Aggregated across thousands of small transactions over a decade, those choices produced the 82% corporate employment share seen today.

How does private equity ownership differ from hospital ownership?

Hospital ownership typically pulls referrals, imaging and surgery inside a single system to capture the full episode of care. Private equity ownership carries a defined holding period and exit requirement, which creates more explicit pressure on volumes and overhead within a set timeframe. Insurer ownership aligns the practice with a payer's cost management goals.

Is physician turnover a financial risk for these owners?

Yes. Physicians are the most expensive and hardest-to-replace labor in clinical businesses. Burnout, unionization and departures raise locum tenens and recruitment costs, and can undercut the volume assumptions an acquisition was priced on. Autonomy complaints often precede turnover, making them a leading indicator of future labor cost.

What could slow further consolidation of physician practices?

Three factors: tighter state enforcement of corporate practice of medicine rules and scrutiny of private equity healthcare deals; stronger collective bargaining by employed physicians changing labor cost assumptions; and evidence linking ownership to measurable care changes, which would strengthen the case for regulatory intervention. Financing conditions also affect deal supply.

Sources

• 4 In 5 Doctors Now Work For ‘Corporate Entities’ As Autonomy Erodes — Forbes Business

Photo: RDNE Stock project · Pexels Licence — source